{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:43:39Z","timestamp":1774615419303,"version":"3.50.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T00:00:00Z","timestamp":1681257600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Chin. J. Integr. Med."],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11655-023-3547-x","type":"journal-article","created":{"date-parts":[[2023,4,12]],"date-time":"2023-04-12T16:03:47Z","timestamp":1681315427000},"page":"143-151","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Berberine Enhances Intestinal Mucosal Barrier Function by Promoting Vitamin D Receptor Activity"],"prefix":"10.1007","volume":"30","author":[{"given":"Yong-quan","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-lin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geng-xin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan-ting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-lin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng-bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiu-ke","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,4,12]]},"reference":[{"key":"3547_CR1","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s12876-020-01336-6","volume":"20","author":"X Zhuang","year":"2020","unstructured":"Zhuang X, Tian Z, Luo M, Xiong L. Short-course Rifaximin therapy efficacy and lactulose hydrogen breath test in Chinese patients with diarrhea-predominant irritable bowel syndrome. BMC Gastroenterol 2020;20:187.","journal-title":"BMC Gastroenterol"},{"key":"3547_CR2","doi-asserted-by":"publisher","first-page":"4893876","DOI":"10.1155\/2019\/4893876","volume":"2019","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Han S, He Y. Clinical effects and safety of Tongxieyaofang on diarrhea predominant irritable bowel syndrome: a meta-analysis of randomized trails. Evid Based Complement Alternat Med 2019;2019:4893876.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3547_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.5056\/jnm.2013.19.2.244","volume":"19","author":"H Lee","year":"2013","unstructured":"Lee H, Park JH, Park DI, Kim HJ, Cho YK, Sohn CI, et al. Mucosal mast cell count is associated with intestinal permeability in patients with diarrhea predominant irritable bowel syndrome. J Neurogastroenterol Motil 2013;19:244\u2013250.","journal-title":"J Neurogastroenterol Motil"},{"key":"3547_CR4","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1186\/s12906-020-03059-3","volume":"20","author":"C Zhang","year":"2020","unstructured":"Zhang C, Huang Y, Li P, Chen X, Liu F, Hou Q. Ginger relieves intestinal hypersensitivity of diarrhea predominant irritable bowel syndrome by inhibiting proinflammatory reaction. BMC Complement Med Ther 2020;20:279.","journal-title":"BMC Complement Med Ther"},{"key":"3547_CR5","doi-asserted-by":"publisher","first-page":"272","DOI":"10.5056\/jnm15138","volume":"22","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Li Y, Hao Z, Li X, Bo P, Gong W. Association of the serotonin receptor 3E gene as a functional variant in the MicroRNA-510 target site with diarrhea predominant irritable bowel syndrome in Chinese women. J Neurogastroenterol Motil 2016;22:272\u2013281.","journal-title":"J Neurogastroenterol Motil"},{"key":"3547_CR6","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fncel.2019.00030","volume":"13","author":"YC Yu","year":"2019","unstructured":"Yu YC, Li J, Zhang M, Pan JC, Yu Y, Zhang JB, et al. Resveratrol improves brain-gut axis by regulation of 5-HT-dependent signaling in the rat model of irritable bowel syndrome. Front Cell Neurosci 2019;13:30.","journal-title":"Front Cell Neurosci"},{"key":"3547_CR7","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/nmo.12851","volume":"28","author":"A Abbasnezhad","year":"2016","unstructured":"Abbasnezhad A, Amani R, Hajiani E, Alavinejad P, Cheraghian B, Ghadiri A. Effect of vitamin D on gastrointestinal symptoms and health-related quality of life in irritable bowel syndrome patients: a randomized double-blind clinical trial. Neurogastroenterol Motil 2016;28:1533\u20131544.","journal-title":"Neurogastroenterol Motil"},{"key":"3547_CR8","doi-asserted-by":"publisher","first-page":"2256","DOI":"10.1159\/000486059","volume":"44","author":"Q Hou","year":"2017","unstructured":"Hou Q, Huang Y, Zhu S, Li P, Chen X, Hou Z, et al. MiR-144 increases intestinal permeability in IBS-D rats by targeting OCLN and ZO1. Cell Physiol Biochem 2017;44:2256\u20132268.","journal-title":"Cell Physiol Biochem"},{"key":"3547_CR9","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1186\/s13568-020-01088-2","volume":"10","author":"J Shao","year":"2020","unstructured":"Shao J, Zeng D, Tian S, Liu G, Fu J. Identification of the natural product berberine as an antiviral drug. AMB Express 2020;10:164.","journal-title":"AMB Express"},{"key":"3547_CR10","doi-asserted-by":"publisher","first-page":"113206","DOI":"10.1016\/j.jep.2020.113206","volume":"264","author":"D Zhang","year":"2021","unstructured":"Zhang D, Jiang L, Wang M, Jin M, Zhang X, Liu D, et al. Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration. J Ethnopharmacol 2021;264:113206.","journal-title":"J Ethnopharmacol"},{"key":"3547_CR11","doi-asserted-by":"publisher","first-page":"175628482096129","DOI":"10.1177\/1756284820961299","volume":"13","author":"M Yu","year":"2020","unstructured":"Yu M, Jin X, Liang C, Bu F, Pan D, He Q, et al. Berberine for diarrhea in children and adults: a systematic review and meta-analysis. Ther Adv Gastroenterol 2020;13:1756284820961299.","journal-title":"Ther Adv Gastroenterol"},{"key":"3547_CR12","doi-asserted-by":"publisher","first-page":"109206","DOI":"10.1016\/j.biopha.2019.109206","volume":"118","author":"Q Hou","year":"2019","unstructured":"Hou Q, Zhu S, Zhang C, Huang Y, Guo Y, Li P, et al. Berberine improves intestinal epithelial tight junctions by upregulating A20 expression in IBS-D mice. Biomed Pharmacother 2019;118:109206.","journal-title":"Biomed Pharmacother"},{"key":"3547_CR13","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1002\/jbmr.3096","volume":"32","author":"Y Nakamichi","year":"2017","unstructured":"Nakamichi Y, Udagawa N, Horibe K, Mizoguchi T, Yamamoto Y, Nakamura T, et al. VDR in osteoblast-lineage cells primarily mediates vitamin D treatment-induced increase in bone mass by suppressing bone resorption. J Bone Miner Res 2017;32:1297\u20131308.","journal-title":"J Bone Miner Res"},{"key":"3547_CR14","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1089\/jir.2018.0144","volume":"39","author":"S Borzouei","year":"2019","unstructured":"Borzouei S, Sheikh V, Ghasemi M, Zamani A, Telikani Z, Zareighane Z, et al. Anti-inflammatory effect of combined sitagliptin and vitamin D3 on cytokines profile in patients with type 2 diabetes mellitus. J Interferon Cytokine Res 2019;39:293\u2013301.","journal-title":"J Interferon Cytokine Res"},{"key":"3547_CR15","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1007\/s40618-019-01123-5","volume":"43","author":"D Gallo","year":"2020","unstructured":"Gallo D, Mortara L, Gariboldi MB, Cattaneo SAM, Rosetti S, Gentile L, et al. Immunomodulatory effect of vitamin D and its potential role in the prevention and treatment of thyroid autoimmunity: a narrative review. J Endocrinol Invest 2020;43:413\u2013429.","journal-title":"J Endocrinol Invest"},{"key":"3547_CR16","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1097\/INF.0b013e3182868989","volume":"32","author":"KA Thornton","year":"2013","unstructured":"Thornton KA, Marin C, Mora-Plazas M, Villamor E. Vitamin D deficiency associated with increased incidence of gastrointestinal and ear infections in school-age children. Pediatr Infect Dis J 2013;32:585\u2013593.","journal-title":"Pediatr Infect Dis J"},{"key":"3547_CR17","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1080\/10409238.2019.1611734","volume":"54","author":"MT Cantorna","year":"2019","unstructured":"Cantorna MT, Snyder L, Arora J. Vitamin A and vitamin D regulate the microbial complexity, barrier function, and the mucosal immune responses to ensure intestinal homeostasis. Crit Rev Biochem Mol Biol 2019;54:184\u2013192.","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"3547_CR18","doi-asserted-by":"publisher","first-page":"G208","DOI":"10.1152\/ajpgi.00398.2007","volume":"294","author":"J Kong","year":"2008","unstructured":"Kong J, Zhang Z, Musch MW, Ning G, Sun J, Hart J, et al. Novel role of the vitamin D receptor in maintaining the integrity of the intestinal mucosal barrier. Am J Physiol Gastrointest Liver Physiol 2008;294:G208\u2013216.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"3547_CR19","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1159\/000506149","volume":"27","author":"SM Khalighi","year":"2020","unstructured":"Khalighi SM, Mokhtare M, Janani L, Faghihi Kashani AH, Masoodi M, Agah S, et al. Vitamin D3 supplementation in diarrhea-predominant irritable bowel syndrome patients: the effects on symptoms improvement, serum corticotropin-releasing hormone, and interleukin-6\u2014a randomized clinical trial. Complement Med Res 2020;27:302\u2013309.","journal-title":"Complement Med Res"},{"key":"3547_CR20","first-page":"652","volume":"19","author":"M Khalighi Sikaroudi","year":"2020","unstructured":"Khalighi Sikaroudi M, Mokhtare M, Shidfar F, Janani L, Faghihi Kashani A, Masoodi M, et al. Effects of vitamin D3 supplementation on clinical symptoms, quality of life, serum serotonin (5-hydroxytryptamine), 5-hydroxy-indole acetic acid, and ratio of 5-HIAA\/5-HT in patients with diarrhea-predominant irritable bowel syndrome: a randomized clinical trial. EXCLI J 2020;19:652\u2013667.","journal-title":"EXCLI J"},{"key":"3547_CR21","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1111\/jgh.15225","volume":"36","author":"K Miura","year":"2021","unstructured":"Miura K, Oshima T, Ito C, Horikawa T, Yamada M, Tomita T, et al. Vitamin D receptor is overexpressed in the duodenum of patients with irritable bowel syndrome. J Gastroenterol Hepatol 2021;36:951\u2013958.","journal-title":"J Gastroenterol Hepatol"},{"key":"3547_CR22","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1210\/en.2017-00748","volume":"159","author":"L He","year":"2018","unstructured":"He L, Liu T, Shi Y, Tian F, Hu H, Deb DK, et al. Gut epithelial vitamin D receptor regulates microbiota-dependent mucosal inflammation by suppressing intestinal epithelial cell apoptosis. Endocrinology 2018;159:967\u2013979.","journal-title":"Endocrinology"},{"key":"3547_CR23","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/aps.2014.170","volume":"36","author":"FY Wang","year":"2015","unstructured":"Wang FY, Su M, Zheng YQ, Wang XG, Kang N, Chen T, et al. Herbal prescription Chang\u2019 an II repairs intestinal mucosal barrier in rats with post-inflammation irritable bowel syndrome. Acta Pharmacol Sin 2015;36:708\u2013715.","journal-title":"Acta Pharmacol Sin"},{"key":"3547_CR24","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1186\/s12906-019-2749-4","volume":"19","author":"Q Hou","year":"2019","unstructured":"Hou Q, Huang Y, Zhu Z, Liao L, Chen X, Han Q, et al. Tong-Xie-Yao-Fang improves intestinal permeability in diarrhoea-predominant irritable bowel syndrome rats by inhibiting the NF-kappaB and notch signalling pathways. BMC Complement Altern Med 2019;19:337.","journal-title":"BMC Complement Altern Med"},{"key":"3547_CR25","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1111\/apt.13746","volume":"44","author":"MR Blake","year":"2016","unstructured":"Blake MR, Raker JM, Whelan K. Validity and reliability of the Bristol Stool Form Scale in healthy adults and patients with diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2016;44:693\u2013703.","journal-title":"Aliment Pharmacol Ther"},{"key":"3547_CR26","doi-asserted-by":"publisher","first-page":"656","DOI":"10.5056\/jnm18037","volume":"24","author":"Q Hou","year":"2018","unstructured":"Hou Q, Huang Y, Zhang C, Zhu S, Li P, Chen X, et al. MicroRNA-200a targets cannabinoid receptor 1 and serotonin transporter to increase visceral hyperalgesia in diarrhea-predominant irritable bowel syndrome rats. J Neurogastroenterol Motil 2018;24:656\u2013668.","journal-title":"J Neurogastroenterol Motil"},{"key":"3547_CR27","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.3892\/etm.2017.4200","volume":"13","author":"QK Hou","year":"2017","unstructured":"Hou QK, Huang YQ, Luo YW, Wang B, Liu YM, Deng RD, et al. (+)-Cholesten-3-one induces osteogenic differentiation of bone marrow mesenchymal stem cells by activating vitamin D receptor. Exp Ther Med 2017;13:1841\u20131849.","journal-title":"Exp Ther Med"},{"key":"3547_CR28","doi-asserted-by":"publisher","first-page":"10855","DOI":"10.1073\/pnas.1121390109","volume":"109","author":"BR Tash","year":"2012","unstructured":"Tash BR, Bewley MC, Russo M, Keil JM, Griffin KA, Sundstrom JM, et al. The occludin and ZO-1 complex, defined by small angle X-ray scattering and NMR, has implications for modulating tight junction permeability. Proc Natl Acad Sci U S A 2012;109:10855\u201310860.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3547_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/modpathol.3800042","volume":"17","author":"SD Billings","year":"2004","unstructured":"Billings SD, Walsh SV, Fisher C, Nusrat A, Weiss SW, Folpe AL. Aberrant expression of tight junction-related proteins ZO-1, claudin-1 and occludin in synovial sarcoma: an immunohistochemical study with ultrastructural correlation. Mod Pathol 2004;17:141\u2013149.","journal-title":"Mod Pathol"},{"key":"3547_CR30","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1111\/jdv.12736","volume":"29","author":"B Visconti","year":"2015","unstructured":"Visconti B, Paolino G, Carotti S, Pendolino AL, Morini S, Richetta AG, et al. Immunohistochemical expression of VDR is associated with reduced integrity of tight junction complex in psoriatic skin. J Eur Acad Dermatol Venereol 2015;29:2038\u20132042.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"3547_CR31","doi-asserted-by":"publisher","first-page":"BSR20201200","DOI":"10.1042\/BSR20201200","volume":"40","author":"B Chen","year":"2020","unstructured":"Chen B, Zhu WF, Mu YY, Liu B, Li HZ, He XF. Association between vitamin D receptor BsmI, FokI, and Cdx2 polymorphisms and osteoporosis risk: an updated meta-analysis. Biosci Rep 2020;40:BSR20201200.","journal-title":"Biosci Rep"},{"key":"3547_CR32","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1007\/s00198-012-2141-4","volume":"24","author":"DJ Stobaugh","year":"2013","unstructured":"Stobaugh DJ, Deepak P, Ehrenpreis ED. Increased risk of osteoporosis-related fractures in patients with irritable bowel syndrome. Osteoporos Int 2013;24:1169\u20131175.","journal-title":"Osteoporos Int"},{"key":"3547_CR33","doi-asserted-by":"publisher","first-page":"508","DOI":"10.5152\/tjg.2021.20614","volume":"32","author":"S Shi","year":"2021","unstructured":"Shi S, Feng J, Zhou L, Li Y, Shi H. Risk factors for vitamin D deficiency in inflammatory bowel disease: a systematic review and meta-analysis. Turk J Gastroenterol 2021;32:508\u2013518.","journal-title":"Turk J Gastroenterol"},{"key":"3547_CR34","doi-asserted-by":"crossref","unstructured":"Linsalata M, Riezzo G, Orlando A, D\u2019Attoma B, Prospero L, Tutino V, et al. The relationship between low serum vitamin D levels and altered intestinal barrier function in patients with IBS diarrhoea undergoing a long-term low-FODMAP diet: novel observations from a clinical trial. Nutrients 2021;13.","DOI":"10.3390\/nu13031011"},{"key":"3547_CR35","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3389\/fphar.2020.01210","volume":"11","author":"L Li","year":"2020","unstructured":"Li L, Cui H, Li T, Qi J, Chen H, Gao F, et al. Synergistic effect of berberine-based Chinese medicine assembled nanostructures on diarrhea-predominant irritable bowel syndrome in vivo. Front Pharmacol 2020;11:1210.","journal-title":"Front Pharmacol"},{"key":"3547_CR36","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.jsbmb.2015.01.011","volume":"148","author":"YC Li","year":"2015","unstructured":"Li YC, Chen Y, Du J. Critical roles of intestinal epithelial vitamin D receptor signaling in controlling gut mucosal inflammation. J Steroid Biochem Mol Biol 2015;148:179\u2013183.","journal-title":"J Steroid Biochem Mol Biol"},{"key":"3547_CR37","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/17474124.2019.1570137","volume":"13","author":"SM Barbalho","year":"2019","unstructured":"Barbalho SM, Goulart RA, Araujo AC, Guiguer EL, Bechara MD. Irritable bowel syndrome: a review of the general aspects and the potential role of vitamin D. Expert Rev Gastroenterol Hepatol 2019;13:345\u2013359.","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"3547_CR38","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s11655-015-2280-5","volume":"25","author":"X Fang","year":"2019","unstructured":"Fang X, Miao XL, Liu JL, Zhang DW, Wang M, Zhao DD, et al. Berberine induces cell apoptosis through cytochrome C\/apoptotic protease-activating factor 1\/Caspase-3 and apoptosis inducing factor pathway in mouse insulinoma cells. Chin J Integr Med 2019;25:853\u2013860.","journal-title":"Chin J Integr Med"},{"key":"3547_CR39","doi-asserted-by":"publisher","unstructured":"Yue SJ, Wang WX, Zhang L, Liu J, Feng WW, Gao H, et al. Anti-obesity and gut microbiota modulation effect of Astragalus Polysaccharides combined with berberine on high-fat diet-fed obese mice. Chin J Integr Med 2021; DOI: https:\/\/doi.org\/10.1007\/s11655-021-3303-z.","DOI":"10.1007\/s11655-021-3303-z"},{"key":"3547_CR40","doi-asserted-by":"publisher","first-page":"110669","DOI":"10.1016\/j.biopha.2020.110669","volume":"131","author":"Y Yao","year":"2020","unstructured":"Yao Y, Chen H, Yan L, Wang W, Wang D. Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids. Biomed Pharmacother 2020;131:110669.","journal-title":"Biomed Pharmacother"}],"container-title":["Chinese Journal of Integrative Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3547-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11655-023-3547-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11655-023-3547-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T05:36:30Z","timestamp":1705988190000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11655-023-3547-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,12]]},"references-count":40,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["3547"],"URL":"https:\/\/doi.org\/10.1007\/s11655-023-3547-x","relation":{},"ISSN":["1672-0415","1993-0402"],"issn-type":[{"value":"1672-0415","type":"print"},{"value":"1993-0402","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,12]]},"assertion":[{"value":"20 December 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}